Andrew Rhoades

Wildfire smoke associated with reproductive, maternal health issues

Rectal bleeding strong colorectal cancer predictor in younger adults

The type of provider treating a patient with menopause symptoms significantly impacted the patient’s chances of receiving a hormone therapy prescription, according to data presented at the Annual Meeting of The Menopause Society.“Menopause is finally gaining traction in mainstream media, which is rightfully empowering our patients who suffer from menopause symptoms to come to us for

There is mixed evidence on how hormone therapy impacts mental health disorders, according to two abstracts presented at the Annual Meeting of The Menopause Society.Both studies indicate that certain factors, including hormone therapy (HT) administration route and menopause status, may influence its impact on conditions like anxiety. The results highlight the importance of individualized treatment

Tramadol is widely prescribed for chronic pain but recently failed to meet a predefined minimal important difference threshold in a systematic review and meta-analysis published in BMJ Evidence Based Medicine.The drug also increased the risk for serious adverse events, including heart disease and some cancers.

Alcohol-induced deaths nearly doubled in the United States from 1999 to 2024, a new analysis published in PLOS Global Public Health showed.The data show a need for “targeted prevention and treatment efforts,” especially for certain demographics that experienced disproportionally large increases, the researchers wrote.

Clinical practice attrition rose from 2013 to 2019, according to a new longitudinal analysis published in the Annals of Internal Medicine. Furthermore, practicing in several certain specialties, including primary care, increased the risk for attrition.

Enhanced acupuncture and standard acupuncture reduced chronic low back pain-related disability in older adults vs. usual care.Both acupuncture groups had greater improvement in pain intensity vs. usual care.

The FDA has approved a generic form of the abortion pill mifepristone on Sept. 30, just before the government shutdown.The new generic formulation is manufactured by Evita Solutions. It is the second generic for mifepristone. The first generic — produced by GenBioPro — was approved by the FDA in 2019.

Metformin may lower the risk for long COVID at 1 year after SARS-CoV-2 infection in people with overweight or obesity, according to a study published in Clinical Infectious Diseases.The data “emphasize the role of using metformin in early COVID-19 treatment plans” for patients in these weight categories, the researchers wrote.